NAP1051 - CAS 864516-77-8

NAP1051, a biomimetic analog of Lipoxin A4, serves an anti-tumor role by targeting the inflammatory tumor microenvironment. It inhibits the chemotaxis of neutrophils to fMLP and stimulates macrophage efferocytosis by activating AKT. NAP1051 is utilized in research on colorectal cancer.

Akt

Cytoskeletal Signaling, PI3K/Akt/mTOR signaling

864516-77-8

C23H34O5

390.51

C(=C/[C@H]([C@H](CCCC(OC)=O)O)O)\C1=CC(/C=C/[C@@H](CCCCC)O)=CC=C1

-20°C

Ice Packs

Small Compound